Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates  E. Njamkepo, F.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America 
Herpes zoster in non-hospitalized children
V. Bouchez, D. Brun, G. Dore, E. Njamkepo, N. Guiso 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Marked difference between adults and children in Bordetella pertussis DNA load in nasopharyngeal swabs  Y. Nakamura, K. Kamachi, H. Toyoizumi-Ajisaka,
R. Cantón  Clinical Microbiology and Infection 
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
P. Davey, C. Pagliari, A. Hayes  Clinical Microbiology and Infection 
F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz 
Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR  T. Kallonen, J.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Rhodococcus equi pneumonia in a heart transplant recipient in Korea, with emphasis on microbial diagnosis  S.J. Yoo, H. Sung, J.D. Chae, M. -N. Kim, C.H.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
D.G. Scorpio, J. Garyu, N. Barat, J. Stephen Dumler 
Structure of grepafloxacin relative to activity and safety profile
Epidemiological investigation of a case of nosocomial Legionnaires' disease in Taiwan: implications for routine environmental surveillance  S.T. Chien,
Vector control: a cornerstone in the malaria elimination campaign
Inga Odenholt, Elisabeth Löwdin, Otto Cars 
Prevalence of Yersinia plasmid-encoded outer protein (Yop) class-specific antibodies in patients with Hashimoto's thyroiditis  S. Chatzipanagiotou, J.N.
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Development of antimicrobial resistance in Staphylococcus lugdunensis during treatment—report of a case of bacterial arthritis, vertebral osteomyelitis.
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Laboratory diagnosis and biosafety issues of biological warfare agents
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
M. Roche, H. Humphreys, E. Smyth, J. Phillips, R. Cunney, E
Uncommon opportunistic fungi: new nosocomial threats
Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years  T.G. Harrison, N. Doshi, N.K. Fry, C.A.
G. Pappas  Clinical Microbiology and Infection 
H.K. Johansen, K. Kjeldsen, N. Høiby 
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
A. Bryskier  Clinical Microbiology and Infection 
The practice of travel medicine in Europe
B.J.A. Rijnders, E. van Wijngaerden, J. van Eldere, W.E. Peetermans 
Training in infectious diseases and tropical medicine in Britain
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Fibronectin concentrations in catheter sepsis
Andrew M. Middleton, Maureen V. Chadwick, Harold Gaya 
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Evaluation of the performance of the Helico Blot 2
S. Alexiou-Daniel, A. Stylianakis, A. Papoutsi, I. Zorbas, A. Papa, A
The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece  J. Papaparaskevas, J. Stefanou, A. Vatopoulos,
Lymphocyte subset numbers depend on the bacterial origin of sepsis
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Serum ferritin levels in West Nile encephalitis
New oral cephalosporins in pediatric community-acquired infections
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
G.C. Schito  Clinical Microbiology and Infection 
Typing of Clostridium difficile
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Localized Mycobacterium avium complex infection in a patient on HAART
The future of diagnostic bacteriology
Presentation transcript:

Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates  E. Njamkepo, F. Delisle, I. Hagege, G. Gerbaud, N. Guiso  Clinical Microbiology and Infection  Volume 6, Issue 3, Pages 131-136 (March 2000) DOI: 10.1046/j.1469-0691.2000.00032.x Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 One microliter of bacterial suspension (1.8 × 1010CFU/mL) was loaded onto a gel and subjected to electrophoresis. The proteins were transferred to a nitrocellulose membrane which was incubated in human serum as described in Materials and Methods. Suspensions of B. pertussis Tohama phase I, B. pertussis 359 phase IV, B. bronchiseptica Rem 1 phase I, B. bronchiseptica Rem 1 phase IV, B. holmesii 1, B. holmesii ATCC 51541, B. holmesii G7702 and B. holmesii G8341 were used. The sera used comprised a pool of sera from B. pertussis-infected patients (A), a pool of sera from B. bronchiseptica-infected patients (B) and serum from a B. holmesii 1-infected patient (C). Clinical Microbiology and Infection 2000 6, 131-136DOI: (10.1046/j.1469-0691.2000.00032.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 One microliter of bacterial suspension (1.8 × 1010 CFU/mL) was loaded onto a gel and subjected to electrophoresis. The proteins were transferred to a nitrocellulose membrane which was incubated in human serum as described in Materials and Methods. Suspensions of B. holmesii 1 grown at 37°C, B. holmesii 1 grown at 25 °C, B. holmesii ATCC 51541 grown at 37°C and B. holmesii ATCC 51541 grown at 25°C were used. Similar results were obtained for B. holmesii 1 and B. holmesii G8341, and for B. holmesii ATCC 51541, B. holmesii G7702 and B. holmesii G8350. (A) Pool of sera from B. bronchiseptica-infected patients. (B) Pool of sera from B. holmesii-infected patients. Clinical Microbiology and Infection 2000 6, 131-136DOI: (10.1046/j.1469-0691.2000.00032.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions